Belen Prado-Vivar
Title
Cited by
Cited by
Year
SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant
Y Konno, I Kimura, K Uriu, M Fukushi, T Irie, Y Koyanagi, D Sauter, ...
Cell reports 32 (12), 108185, 2020
2022020
COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America.
B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, S Marquez, B Gutierrez, ...
First Confirmed Event in South America.(September 3, 2020), 2020
832020
A case of SARS-CoV-2 reinfection in Ecuador
B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, S Márquez, B Gutierrez, ...
The Lancet Infectious Diseases 21 (6), e142, 2021
532021
Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome
PA Cárdenas, D Garcés, B Prado-Vivar, N Flores, M Fornasini, H Cohen, ...
European Journal of Clinical Microbiology & Infectious Diseases 39 (7), 1365 …, 2020
172020
COVID-19 Re-infection by a phylogenetically distinct SARS-CoV-2 variant
B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, S Marquez, B Gutierrez, ...
First Confirmed Event in South America.(September 3, 2020), 2020
102020
Genome sequencing of the first SARS-CoV-2 reported from patients with COVID-19 in Ecuador
S Marquez, B Prado-Vivar, JJ Guadalupe, B Gutierrez, M Jibaja, M Tobar, ...
medRxiv, 2020
72020
COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America. SSRN Electron J [Internet]. 2020
B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, S Marquez, B Gutierrez, ...
7
COVID-19 re-infection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America. SSRN 2020; published online Sept 8
B Prado-Vivar, M Becerra-Wong, JJ Guadalupe
7
COVID-19 reinfection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America. SSRN. 2020
B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, S Marquez
62020
Molecular typing of a large nosocomial outbreak of KPC-producing bacteria in the biggest tertiary-care hospital of Quito, Ecuador
MB Prado-Vivar, L Ortiz, J Reyes, E Villacis, M Fornasini, ME Baldeon, ...
Journal of global antimicrobial resistance 19, 328-332, 2019
42019
Duodenal microbiome in patients with or without Helicobacter pylori infection
A Suárez‐Jaramillo, ME Baldeón, B Prado, M Fornasini, H Cohen, ...
Helicobacter 25 (6), e12753, 2020
32020
Genomic epidemiology of SARS-CoV-2 transmission lineages in Ecuador
B Gutierrez, S Márquez, B Prado-Vivar, M Becerra-Wong, JJ Guadalupe, ...
medRxiv, 2021
12021
SARS-CoV-2 detection and sequencing in heart tissue associated with myocarditis and persistent arrhythmia: a case report
D Egas, JJ Guadalupe, B Prado-Vivar, M Becerra-Wong, S Márquez, ...
IDCases, e01187, 2021
2021
SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis.
S Márquez, B Prado-Vivar, JJ Guadalupe, M Becerra-Wong, B Gutierrez, ...
medRxiv, 2021
2021
Metagenome of a Bronchoalveolar Lavage Fluid Sample from a Confirmed COVID-19 Case in Quito, Ecuador, Obtained Using Oxford Nanopore MinION Technology
S Márquez, B Prado-Vivar, JJ Guadalupe, B Gutierrez, M Becerra-Wong, ...
Microbiology Resource Announcements 9 (41), e00996-20, 2020
2020
Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome
P Cardenas, M Baldeon, H Cohen, M Fornasini, D Garces, B Prado, ...
HELICOBACTER 24, 2019
2019
Sa1932–Effect of Saccharomyces Boulardii Cncm I-745 on the Gut Microbiome As a Complementary Treatment Against Helicobacter Pylori Infection
P Cardenas, D Garces, B Prado, MV Fornasini, H Cohen, M Baldeon
Gastroenterology 156 (6), S-458-S-459, 2019
2019
Emergence of lineage B. 1.621 in Latin America and the Caribbean
B Gutierrez, S Márquez, B Prado-Vivar, M Becerra-Wong, F Zurita, ...
The system can't perform the operation now. Try again later.
Articles 1–18